The Canadian administration has tremendously become strict regarding the requirements for the drug manufacturers. These requirements are just like the requirements for drug manufacturers in the United States. Most standard drugs are produced in Canada beneath these firm laws.
Most of the drugs produced in Canada are much cheaper than the drugs of allied chemical composition that are produced in the United States. Canada has a rule of minimizing the drug expenses through its state health assurance policy. As a result, Canada is able to produce much cheaper drugs as compared to the United States.
Canada produces a small amount of standard recommended drugs for its personal use. Importing the remaining amount of drugs from the other countries around the world fills up the shortfall of drugs. The original drugs cost assessment panel keeps the prices on a higher side, disappointing the new or the inexperienced drug producers from using cost reduction as a competitive strategy.
This allows the companies that manufacture standard drugs to charge a higher cost and prevents them from any danger of price rivalry among trade name competitors. As a result, the new or the inexperienced drug manufacturers have to suffer.
